Sign in
Active, not recruitingNo phase

TRACK-TBI Longitudinal Biomarker Study

Key facts

Who runs it
University of Pennsylvania
Where
Austin, Charlestown, Cincinnati, Dallas, Houston, Philadelphia, Pittsburgh, Richmond, Salt Lake City, San Francisco, and Seattle, United StatesSee the 11 sites
Trial code
Status
Active, not recruiting
People taking part
300 people, planned
Started
1 Mar 2022
Expected to end
28 Feb 2027
Type of study
Observational, 3 groups
Treatments tested
  • Telephone Outcome Assessment
  • In-Person Outcome Assessment
  • 3T Magnetic Resonance Imaging (MRI)
  • Blood Draw
Record updated
17 August 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • LONGITUDINAL Telephone Assessment:
  • Participated in TRACK-TBI,
  • At least two years post injury, and
  • Completed at least 1 GOSE during the TRACK-TBI follow-up assessments
  • LONGITUDINAL BIOMARKER In-Person Assessment:; Must complete at least one Longitudinal Telephone Assessment and fall into one of the following groups:
  • Group 1- Completed TRACK-TBI 6M MRI and are stable or improved with regard to Criteria for Establishing Decline
  • Group 2- Criteria for Establishing Decline met when comparing the Telephone Assessments to the last completed TRACK-TBI assessment
  • Group 3- All TRACK-TBI orthopedic controls; Ability of participant or legally authorized representative to provide informed consent

Who cannot take part

  • Dementia diagnosed prior to the index TBI

Where in United States

  • University of Texas at AustinAustin, United States
  • Spaulding Rehabilitation HospitalCharlestown, United States
  • University of CincinnatiCincinnati, United States
  • University of Texas, SouthwesternDallas, United States
  • Baylor College of MedicineHouston, United States
  • University of Pennsylvania/Penn Presbyterian Medical CenterPhiladelphia, United States
  • University of PittsburghPittsburgh, United States
  • Virginia Commonwealth UniversityRichmond, United States
  • University of UtahSalt Lake City, United States
  • University of California San FranciscoSan Francisco, United States
  • University of WashingtonSeattle, United States

About the trial

What the trial wants to find out

The overarching goal of this study is to improve understanding of the long-range natural history of TBI by extending follow-up of a previously enrolled cohort (TRACK-TBI) beyond the first 12 months after injury.

The 3 groups in the trial

  • Telephone Assessment Battery

    TRACK-TBI participants may complete up to three annual telephone calls to assess outcome status. These assessments will determine eligibility for the in-person study visit.

    Treatment: Telephone Outcome Assessment

  • Comprehensive Assessment Battery (CAB)

    Participants who demonstrate decision-making capacity will be asked to complete the Comprehensive Assessment Battery (CAB). The CAB in-person is comprised of measures of cognition (i.e. attention, memory, information processing speed, executive functions), mood (i.e., depression, anxiety), social participation, subjective well-being, post-traumatic stress, interviews, global functional status measures, and a COVID-19 questionnaire.

    Treatment: Telephone Outcome Assessment, In-Person Outcome Assessment, 3T Magnetic Resonance Imaging (MRI), and Blood Draw

  • Abbreviated Assessment Battery (AAB)

    Participants who do not have decision-making capacity will be asked to complete a modified assessment battery, called the Abbreviated Assessment Battery (AAB). The AAB in-person assessment will administer the Speech Intelligibility, GOAT, and CAP and/or CRS-R to study participants.

    Treatment: Telephone Outcome Assessment, In-Person Outcome Assessment, 3T Magnetic Resonance Imaging (MRI), and Blood Draw

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI)- a Longitudinal Biomarker Study
Record updated
17 August 2026